RECOMMENDED

  1. A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients
    Betül Oran et al., Blood Advances, 2020
  2. Comparative Analysis of the Value of Allogeneic Hematopoietic Stem-Cell Transplantation in Acute Myeloid Leukemia With Monosomal Karyotype Versus Other Cytogenetic Risk Categories
    Jan J. Cornelissen et al., J Clin Oncol, 2012
  3. Better the cure you know: why patients with AML ≥60 years of age should be offered early allogeneic stem cell transplantation
    Siok-Keen Tey et al., Blood Advances, 2022
  4. Data Mount for Venetoclax as Add-on Therapy in Acute Myeloid Leukemia
    By Caroline Helwick, The ASCO Post, 2019
Powered by
  • Targeting settings
  • Do not sell my personal information
  • Google Analytics settings
I consent to the use of Google Analytics and related cookies across the TrendMD network (widget, website, blog). Learn more